HEALTH● LOWSep 17 · Sep 17, 2026, 3:46 PM
Novo Nordisk (NVO) and Eli Lilly (LLY)’s Weight-Loss Drugs Still Work at Smaller Doses, Study Finds
Yahoo Finance · global
A study indicates that weight-loss drugs from Novo Nordisk and Eli Lilly remain effective even at smaller doses. This finding has implications for medical treatment and pharmaceutical development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH28m agoToluwanisings was rushed to 8 hospitals before death – PAVanguard NigeriaHEALTH1h agoPope Leo resumes work from the hospital as he awaits cancer treatment updateThe Independent WorldHEALTH1h agoKenya records second Ebola case as outbreak in Congo keeps growingEuroNews [en]HEALTH1h agoI work in the NHS and Malawi – we need to urgently rethink how we see health spendingThe Independent World